"Over the past five years, we've been spending time increasingly in New York, and we have several portfolio companies there now," says Aronoff, mentioning startups like 10Gen, a database company, and 33Across, in advertising technology. "Our deal flow in New York has really risen, and for the past couple years we've been holding one of our partner meetings every month in New York." (Aronoff adds that several of Flybridge's Boston-based portfolio companies, like Dataxu, also have sales and marketing offices in Manhattan.)
While the New York tech scene in the late 1990s may have "turned out to be a mirage," Aronoff contends that this time, it's different: "It's a really interesting ecosystem of entrepreneurs, and we're seeing things that are keeping us interested."
The Flybridge office is in SoHo, not far from where the TechStars New York accelerator program is located.
(As an aside: well worth a read is this recent blog post from Jeffrey Bussgang, a colleague of Aronoff's at Flybridge, which compares the recent IPO and M&A track records of New York and Boston.)
About Scott Kirsner
Scott Kirsner was part of the team that launched Boston.com in 1995, and has been writing a column for the Globe since 2000. His work has also appeared in Wired, Fast Company, The New York Times, BusinessWeek, Newsweek, and Variety. Scott is also the author of the books "Fans, Friends & Followers" and "Inventing the Movies," was the editor of "The Convergence Guide: Life Sciences in New England," and was a contributor to "The Good City: Writers Explore 21st Century Boston." Scott also helps organize several local events on entrepreneurship, including the Nantucket Conference and Future Forward. Here's some background on how Scott decides what to cover, and how to pitch him a story idea.
Subscribe via e-mail
More from Scott
March 3: Web Innovators Group
Demos, drinks, and schmoozing at the Royal Sonesta in Cambridge.
March 7-8: MassDigi Game Challenge
Competition for aspiring game developers... plus panels and keynotes related to the business of play.
April 3-4: Mass Biotech Annual Meeting
Issues facing the region's life sciences community.